RxDoctor Payments Data

Iroabuchi Idika, MD

Psychiatry · Columbia, MONPI 1730530676

Payments from drug & device makers

$432in general payments, 2019–2025

Across 24 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • Lundbeck LLC$52
  • Alkermes, Inc.$48
  • Sunovion Pharmaceuticals Inc.$44
  • Indivior Inc.$39
  • Otsuka America Pharmaceutical, Inc.$31
  • plus $40 from 2 others

What the payments were for

  • Food & beverage$432100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$432 in reported general payments places this provider in the 55th percentile of 680 psychiatry providers in Missouri.

See all psychiatry providers in Missouri

Medicare billing

Part B allowed, 2024
$4,688
Medicare patients
29
Services billed
47

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate55$153,727
IngrezzaValbenazine Tosylate13$113,037
VraylarCariprazine Hcl32$48,726
Risperidone ErRisperidone Microspheres18$20,300
RexultiBrexpiprazole13$20,193
Aripiprazole114$8,290
Ramelteon43$7,457
Paliperidone ErPaliperidone48$7,115
TrintellixVortioxetine Hydrobromide12$6,076
Lurasidone Hcl19$5,492
Bupropion XlBupropion Hcl64$4,578
Clozapine50$3,342
Olanzapine61$2,381
Buspirone Hcl140$2,008
Quetiapine Fumarate83$1,646

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$22$113,03713 claims
AbbVieVraylar$177$48,72632 claims
Otsuka America Pharmaceutical, Inc.Rexulti$31$20,19313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 680 psychiatry providers in Missouri.

Other psychiatry in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →